These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome.
    Author: Bećarević M, Singh S, Majkić-Singh N.
    Journal: Clin Biochem; 2007 Mar; 40(5-6):317-20. PubMed ID: 17291477.
    Abstract:
    OBJECTIVE: To investigate whether lipoprotein (a) (Lp(a)) and/or apolipoprotein (a) (apo(a)) may be markers for clinical features of 37 patients with primary antiphospholipid syndrome (PAPS) and to compare with 37 age- and sex-matched controls. METHODS: Apo(a) and Lp(a) concentrations were determined by ELISA and immunonephelometry, respectively. RESULTS: Only elevated apo(a) concentrations were significant predictor for cerebrovascular insults (OR=14.399, p=0.005, 95% CI: 2.224-93.230). CONCLUSION: Considering the fact that PAPS patients with cerebrovascular insults had recurrence of cerebrovascular episodes, measurement of apo(a) concentrations will help in the follow-up of those patients and thus in the prediction of future episodes. This finding should be further investigated in a larger study in order to provide adequate therapeutic intervention.
    [Abstract] [Full Text] [Related] [New Search]